The 52-Week Low Club
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Neurochem (NRMX) Continues to race for the bottom. On Monday, the company said its Alzheimer’s disease treatment candidate, Alzhemed, failed a late-stage trial. The NRMX says it has 15 to 18 months of cash left. Maybe. Drops to $2.16 from 52-week high of $26.51.
Conexant (CNXT) Israel’s Orckit Communications wins arbitration and CNXT has to pay $12 million. Does not seem like a lot but stock drops to $1.06 from 52-week high of $2.36.
Tenet Healthcare (THC) Credit Suisse analyst launched coverage on the company with an "Underperform" rating. Down to $3.29 from 52-week high of $8.69.
Lennar (LEN) Home builder. Enough said. Down to $27.26 from 52-week high of $56.54.
Centex (CTX) Home builder. Ditto. Down to $28.13 from 52-week high of $58.42.
Horton (DHI) Another home builder. Drops to $14.40 from 52-week high of $31.13.
Leapfrog (LF) Bad quarter recently and toy companies are not all the rage right now. Down to $6.91 from 52-week high of $11.56.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.